Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of cancer immunotherapies, announced the expansion of its Scientific Advisory Board with the appointments of two leaders in the cell therapy field, James Mulé, IPh.D., and Eric Tran, Ph.D.
December 15, 2021
· 4 min read